Liu SS, Wan QS, Lv C, Wang JK, et al. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer. BMC Cancer 2024;24:465.
PMID: 38622522